Startseite Naturwissenschaften Crystal structure of dimethyl 3,9-dibenzyl-6,12-dicyclohexyl-3,9-diazahexacyclo [6.4.0.02,7.04,11.05,10]-dodecane-1,11-dicarboxylate, C40H50N2O4
Artikel Open Access

Crystal structure of dimethyl 3,9-dibenzyl-6,12-dicyclohexyl-3,9-diazahexacyclo [6.4.0.02,7.04,11.05,10]-dodecane-1,11-dicarboxylate, C40H50N2O4

  • Hao Zhu , Yi-Fan Li , Ying-Ying Guo , Shan Liu , Han-Yang Lan , Peng-Yu Zhuang und Qi-Di Zhong EMAIL logo
Veröffentlicht/Copyright: 12. Februar 2018

Abstract

C40H50N2O4, monoclinic, P21/c (no. 14), a = 10.355(2) Å, b = 17.809(4) Å, c = 8.9354(16) Å, β = 97.101(4)°, V = 1635.2(5) Å3, Z = 2, Rgt(F) = 0.0453, wRref(F2) = 0.1270, T = 113 K.

CCDC no.: 1576541

The cage centrosymmetric dimer of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless prism
Size:0.2 × 0.8 × 0.12 mm
Wavelength:Mo radiation (0.71073 Å)
μ:0.81 cm−1
Diffractometer, scan mode:Rigaku XtaLAB P200, φ and ω
2θmax, completeness:55.2°, >99%
N(hkl)measured, N(hkl)unique, Rint:16583, 3765, 0.0247
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3411
N(param)refined:209
Programs:Rigaku [1], OLEX2 [2], ShelXL [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.15997(8)0.08849(5)0.86867(10)0.0195(2)
O20.12979(8)−0.03622(5)0.88370(10)0.0217(2)
N10.52972(9)0.04945(5)0.81502(10)0.0134(2)
C10.61223(11)0.05978(6)0.95856(12)0.0132(2)
H10.68520.09570.95040.016*
C20.53807(11)0.07687(6)1.09744(12)0.0133(2)
H20.57860.11941.15960.016*
C30.39018(11)0.08561(6)1.06362(12)0.0129(2)
H30.37310.13060.99720.016*
C40.33957(11)0.01678(6)0.97137(12)0.0129(2)
C50.42058(10)0.00086(6)0.83221(12)0.0132(2)
H50.3618−0.00480.73530.016*
C60.49645(11)0.12002(7)0.73421(13)0.0173(2)
H6A0.47010.15780.80590.021*
H6B0.42160.11140.65590.021*
C70.60981(11)0.15012(7)0.66070(13)0.0167(2)
C80.66140(12)0.22057(7)0.69749(14)0.0201(3)
H80.62580.25010.77100.024*
C90.76497(13)0.24872(8)0.62794(15)0.0241(3)
H90.79900.29720.65350.029*
C100.81767(13)0.20568(8)0.52174(15)0.0262(3)
H100.88810.22470.47440.031*
C110.76794(13)0.13437(8)0.48372(15)0.0260(3)
H110.80460.10470.41140.031*
C120.66405(13)0.10728(7)0.55290(14)0.0224(3)
H120.62940.05900.52660.027*
C130.33091(11)0.10193(6)1.21243(13)0.0145(2)
H130.39850.08811.29780.017*
C140.30771(13)0.18651(7)1.22404(14)0.0196(3)
H14A0.38890.21361.21050.023*
H14B0.24000.20211.14190.023*
C150.26481(14)0.20837(7)1.37554(14)0.0237(3)
H15A0.33650.19831.45710.028*
H15B0.24530.26281.37570.028*
C160.14437(13)0.16425(8)1.40535(15)0.0266(3)
H16A0.06940.18011.33270.032*
H16B0.12380.17571.50820.032*
C170.16455(13)0.07978(8)1.39076(15)0.0239(3)
H17A0.08250.05331.40310.029*
H17B0.23190.06271.47190.029*
C180.20673(12)0.05968(7)1.23670(14)0.0197(3)
H18A0.22220.00491.23180.024*
H18B0.13640.07291.15570.024*
C190.19836(11)0.01828(6)0.90829(12)0.0147(2)
C200.02647(12)0.09664(8)0.80188(16)0.0262(3)
H20A0.01190.06660.70950.039*
H20B0.00860.14960.77760.039*
H20C−0.03170.07930.87330.039*

Source of material

The title compound was synthesized by methyl 1-benzyl-1,4-dihydro-4-cyclohexylpyridine-3-carboxylate under irradiation of UV-light in methanol/THF solution. After approximately 24 h. By thin-layer chromatography, the residue was purified using ethyl acetate-petroleum ether (1:40 v/v). After concentration in vacuo colorless solids were collected and dried, and recrystallized from methanol. After 1 week colorless crystals were obtained.

Experimental details

All H atoms were placed in calculated positions (C—H = 0.95–1.00 Å) and refined as riding atoms. The Uiso values were set to be 1.5Ueq of the carrier atom for nitrogen H atoms and 1.2Ueq for the remaining H atoms.

Discussion

Tetraasterane, cubane and homocubane have unique caged structures and lipophilic properties, which have been used in research on energy, functional materials and anti-tumor and antiviral drugs [4]. Recently, the 3,9-diazatetraasteranes possessing C2 symmetry have been suggested to be novel inhibitors of retroviral PR on the basis of molecular modeling results [5]. As competitive inhibitors [6], they are among the most promising classes of novel inhibitors of HIV-1 PR because their bioanalytical profile of poor metabolism and protein binding suggest better oral bioavailabilities. Only a small number of 3,9-diazatetraasterane have been reported so far [7]. In order to search for new 3,9-diazatetraasterane, the title compound was synthesized and its crystal structure was determined.

The molecular structure of the title compound is shown in the figure. All bond lengths and angles are within normal ranges [8]. Crystal structure analysis revealed that the piperidine rings are in chair conformation, the apexes (prows) being the N1 and C3 atoms. In a flat cyclobutane system a significant proportion of the molecular strain comes from the eclipsed orientation of vicinal substituents around the ring. Inward methylene rocking [9] may not be possible to relieve the eclipsed-orientation strain in the present case, because of the N1 and C3 bridges connecting the two cyclobutane rings at all corners.

Because of the Csp2 nature of the substituent at C3, the orientation of the cyclohexyl ring around the C3—C13 bond is characterized by the following torsion angles: C4—C3—C13—C14: −138.44° C2—C3—C13—C14: 98.94°. On the other hand, the torsion angle N1—C6—C7—C8 is −120.74°.

Acknowledgements

This work was financially supported by the Key Projects in the Hebei Youth Natural Science Foundation (No. H2014209241).

References

Rigaku/MSC. CrystalClear. Rigaku/MSC Inc., The Woodlands, TX, USA (2006).Suche in Google Scholar

Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: A complete structure solution, refinement and analysis program. J. Appl. Cryst. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar

Yan, H.; Xing, G. J.; Zhou, L. L.; Huang, J. Y.: synthesis and application of cubanes and homocubans. Chin. J. Org. Chem. 20 (2000) 649–654.Suche in Google Scholar

Hilgeroth, A.; Fleischer, R.; Wiese, M.; Heinemann, F. W.: Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cage dimeric N-benzyl 4-(4-methoxyphenyl)-1,4-dihydropyridine as representative of a novel class of HIV-1 protease inhibitors: a molecular modeling study. J. Comput. Aid. Mol. Des. 13 (1999) 233–242.10.1023/A:1008038608460Suche in Google Scholar

Wlodawer, A.; Vondrasek, J.: Crystal structure of a novel synthetic inhibitor of HIV-1 protease. Ann. Rev. Biophys. Biomol. struct. 27 (1998) 249–284.10.1146/annurev.biophys.27.1.249Suche in Google Scholar

Hilgeroth, A.; Tykarska, E.; Jaskolski, M.: Crystal structure of a novel synthetic inhibitor of HIV-1 protease. J. Mol. Struct. 605 (2002) 63–70.10.1016/S0022-2860(01)00751-7Suche in Google Scholar

Allen, F. H.; Kennard, O.; Watson, D. G.; Brammer, L.; Orpen, A. G.; Taylor, R.: Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. Perkin Trans. 2 (1987) S1–S19.10.1039/p298700000s1Suche in Google Scholar

Allen, F. H.: The geometry of small rings. VI. Geometry and bonding in cyclobutane and cyclobutene. Acta Crystallogr. B40 (1984) 64–72.10.1107/S0108768184001750Suche in Google Scholar

Received: 2017-10-28
Accepted: 2018-1-23
Published Online: 2018-2-12
Published in Print: 2018-3-28

©2018 Hao Zhu et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure and optical properties of diaqua-tris(nitrato-κ2O,O′)-bis(4,4,5,5-tetramethyl-2-(p-pyridyl)imidazoline-1-oxyl 3-oxide-κN)praseodymium(III), C24H36N9O15Pr
  3. Crystal structure of dimethanol-bis(μ2-methanol-κ2O:O)-bis{3-((4-methoxy-2-oxidobenzylidene)amino)-2-oxo-2H-chromen-4-olato-κ3O,N,O′}dimanganese(II), C38H38Mn2N2O14
  4. Crystal structure of catena-poly[diaqua-bis(μ2-2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ3O,O′:O′)calcium(II)], C56H48N4Ca2Cl8O12
  5. Crystal structure of catena-poly[triaqua-(isophthalato-κO)-(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)]nickel(II), C20H28N4NiO7
  6. Crystal structure of cyclo[hexaqua-bis[1-[(2-ethyl-1H-imidazol-1-yl) methyl]-1H-benzotriazole-κ2N:N′]-bis(sulfato-κ1O)dicadmium(II)] monohydrate, C24H42Cd2N10O16S2
  7. Crystal Structure of bis(2-fluorbenzoato-κO)-bis(1,10-phenanthroline-κ2N,N′)manganese(II) dihydrate, C38H28F2MnN4O6
  8. Crystal structure of tetrapropylammonium 5-hydroxyisophthalate tetrahydrate, C20H41NO9
  9. Crystal structural of 2-amino-4-(3-bromophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo[b]pyran, C18H17BrN2O2
  10. Crystal structural of 2-amino-4-(4-methoxyphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H16N2O3
  11. Crystal structure of catena-poly[aqua(μ2-1,3-bis(1H-benzo[d]imidazol-1-yl)propane-κ2N:N′)-(μ2-5-(tert-butyl)isophthalate-κ3O,O′:O′′)nickel(II)], C29H30N4NiO5
  12. Crystal structure of catena-poly[(μ2-dicyanamido-κ2N:N′)-(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O′)copper(II)], C9H8CuN4O
  13. Crystal structure of bis(5,5′-((butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido-k4N,N′,N′′,N′′′)copper(II), C24H32CuN4O4
  14. The crystal structure of the formamide solvate of (17b)-estra-1,3,5(10)-triene-3,17diol, C19H27NO3
  15. Crystal structure of catena-poly[diaqua-bis(μ2-1H-benzo[d]imidazole-5-carboxylato-κ2N:O)nickel(II)] dihydrate, C16H18N4NiO8
  16. Crystal structure of dibromido[(1,2-bis(diisopropylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]nickel(II), C14H38B10NiBr2P2
  17. The crystal structure of catena-poly[aquachlorido(3,3′-([4,4′-bipyridine]-1,1′-diium-1,1′-diylbis(methylene))dibenzoato-κ2O:O′)copper(II)] chloride dihydrate, C26H26Cl2CuN2O7
  18. The crystal structure of N′-(2-nitrobenzylidene)-2-phenylacetohydrazide, C15H13N3O3
  19. Crystal structure of dichlorido bis[1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole-κ1N]cadmium(II), C30H26CdCl2N10
  20. Crystal structure of aqua-bis(3-(2-pyridyl)-5-(4-pyridyl)-1H-1,2,4-triazole-κ2N,N′)copper(II) sulfate tetrahydrate, C24H28CuN10O9S
  21. Crystal structure of dibromido-carbonyl-(η6-p-cymene)osmium(II), C11H14Br2OOs
  22. Crystal structure of catena-poly[chlorido-(μ2-chlorido)-bis(imidazole-κN)copper(II)] C6H8Cl2CuN4
  23. Crystal structure of [(1,2-bis(dicyclohexylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]dibromidonickel(II)), C26H54B10NiBr2P2
  24. Crystal structure of dichlorido[1,1′-bis(diphenylphosphanyl)ferrocene-κ2P,P′]zinc(II), C34H28FeCl2P2Zn
  25. Crystal structure of tris(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O)-trithiocyanato-κN-dicobalt(III), C24H24Co2N6O3S3
  26. The crystal structure of diaqua-2,2′-((cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))diphenolato-κ4N,N′,O,O′)manganese(III) perchlorate, C20H24MnClN2O4
  27. Crystal structure of bis(μ3-chlorido)-bis(μ2-chlorido)-tetrakis(μ2-2,6-bis (diphenylmethyl)-4-t-butylphenolato)tetralithium(I)dicobalt(II) toluene solvate, C75.5H70Cl2CoLi2O2
  28. The crystal structure of hexaaqua-bis(μ2-3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κ2O:O′)-tetrakis(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κO)dierbium(III) octahydrate, C60H76N18O32Er2
  29. Crystal structure of dimethylammonium bis(naphthalene-2,3-diolato)borate, C22H20BNO4
  30. Crystal structure of 2-amino-4-(4-nitro-phenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C18H17N3O4
  31. The crystal structure of (E)-4-chloro-2-(((5-methylpyridin-2-yl)imino)methyl)phenol, C13H11ClN2O
  32. Crystal structure of bis(N,N,N-trimethylbutanaminium) poly[heptaselenidotristannate(IV)], C14H36N2Se7Sn3
  33. The crystal structure of N-((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)-4-methylbenzenesulfonamide, C28H35N3S
  34. Crystal structure of 2-(4-chlorophenyl)-2,3-dihydro-1H-perimidine, C17H13Cl1N2
  35. The Crystal structure of 2-iodo-1-(p-tolyl)propan-1-one, C10H11IO
  36. Crystal structure of ethyl 1-(4-bromobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17BrN2O2
  37. Crystal structure of ethyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17FN2O2
  38. Crystal structure of catena-poly[diaqua-(μ2-2,5-dihydroxyterephthalato-κ4O,O′:O′′,O′′′)cadmium(II)], C8H8O8Cd
  39. Crystal structure of tetraaqua-bis[6-(1H-imidazol-1-yl-κN)nicotinato]zinc(II), C18H20N6O8Zn
  40. Crystal structure of dichlorido-bis(N-phenyl-2-(quinolin-8-yloxy)acetamide-κ2N,O) – acetone (2/1), C35.5H31N4O4.5Cl2Cu
  41. Crystal Structure of ethyl (E)-3,4-dimethyl-5-((2-(4-methylbenzoyl)hydrazono)methyl)-1H-pyrrole-2-carboxylate — water — ethanol (1/1/1), C20H29N3O5
  42. Crystal structure of 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole - trichloromethane - methanol (1/1/1), C20H19Cl4N3O3S
  43. The crystal structure of a matrine derivative: 41S,7aS,12S,13aR,13bR)-12-(4-methylpiperazin-1-yl)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one, C20H34N4O
  44. Crystal structure of cesium beryllophosphate, Be3Cs2P4O14
  45. Crystal Structure of 3-((3-hydroxybenzyl)ammonio)-3-phenylpropanoate, C16H17NO3
  46. Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride — 4-hydroxy-3-methoxybenzoic acid — water (2/1/5), C48H54N2Cl2O17
  47. The crystal structure of (1R, 2R)-N1,N2-diferrocenyl-1,2-cyclohexanedicarboxamide, C28H30Fe2N2O2
  48. Crystal structure of N-(2-methylphenyl)ethoxycarbothioamide, C10H13NOS
  49. Crystal Structure of ethyl (E)-2,4-dimethyl-5-((2-tosylhydrazono)methyl)-1H-pyrrole-3-carboxylate monohydrate, C17H23N3O5
  50. Crystal structure of Diiodo-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3N,N′,O)cadium(II) – dimethylformamide (1/1), C19H19N5O2CdI2
  51. Crystal structure of dinitrato-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3-N,N′,O)copper(II), C16H12N6O7Cu
  52. Crystal structure of benzoato-κO-bis(1,3,5-triaza-7-phosphaadamantane-κP)silver(I) monohydrate C19H31AgN6O3P2
  53. Crystal structure of (E)-2-(anthracen-9-ylmethylene)hydrazine-1-carbothioamide, C16H13N3S
  54. The crystal structure of 8-chloro-7-ethyl-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, C9H11ClN4O2
  55. Crystal structure of {5,5′-((propane-1,3-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′}zinc(II), C23H30N4O4Cu
  56. Crystal structure of bis(4-dimethylamino-pyridin-1-ium)tetrafluorosuccinate, C18H22F4N4O4
  57. Crystal structure of dimethyl 3,9-dibenzyl-6,12-dicyclohexyl-3,9-diazahexacyclo [6.4.0.02,7.04,11.05,10]-dodecane-1,11-dicarboxylate, C40H50N2O4
  58. Crystal structure of diethyl 3,9-diphenyl-6,12-bis(3-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,11-dicarboxylate, C42H42N2O6
  59. Crystal structure of bis(acetato-κO)-bis(1-(pyridin-2-yl)ethan-1-one oxime-κ2N,N′)nickel(II), C18H22N4NiO6
  60. Crystal structure of (N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3N,O,O′)-diphenyltin(IV), C28H23FN2O3Sn
  61. Crystal structure of {N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3O,N,O′}dimethyltin(IV), C18H19FN2O3Sn
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0332/html
Button zum nach oben scrollen